Holiday shipping dates:
Last international orders dispatched: Friday 11th December
Last UK domestic orders dispatched: Wednesday 16th December
Following the holiday period, shipping will resume as normal from the week commencing Monday 4th January 2027
| Institute |
|---|
| A*STAR Accelerate Technologies Pte Ltd |
| SKU: | 152655 |
|---|---|
| Product description: | The hemagglutinin (HA) protein is one of the two major surface glycoproteins on the envelope of influenza A virus. The HA protein is responsible for receptor binding to host cells and for viral entry and is therefore the primary target of neutralizing antibodies. It is a homotrimer, with each subunit made up of two disulfide-linked polypeptides, HA1 and HA2. The N-terminal subunit HA1 contains the receptor binding domain. In this study, the receptor binding domain of the H5N1 avian influenza hemagglutinin (H5) was expressed in E.coli and used as antigen target. This project targets to generate monoclonal antibodies against H5 for diagnostic and therapeutic applications. |
| Conjugation: | Unconjugated |
| Isotype: | IgG2a |
| Immunogen: | 32.5kDa truncated H5 protein |
| Myeloma used: | Sp2/0-Ag14 |
| Cat. #: | 152655 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Microbiology |
| Application: | IF ; WB |
| Target: | tEH5 (32.5kDa) protein, receptor binding domain of influenza hemagglutinin (H5) |
| Reactivity: | Virus |
| Clone: | 1D10 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | The hemagglutinin (HA) protein is one of the two major surface glycoproteins on the envelope of influenza A virus. The HA protein is responsible for receptor binding to host cells and for viral entry and is therefore the primary target of neutralizing antibodies. It is a homotrimer, with each subunit made up of two disulfide-linked polypeptides, HA1 and HA2. The N-terminal subunit HA1 contains the receptor binding domain. In this study, the receptor binding domain of the H5N1 avian influenza hemagglutinin (H5) was expressed in E.coli and used as antigen target. This project targets to generate monoclonal antibodies against H5 for diagnostic and therapeutic applications. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.